Valerie Darling Email & Phone Number

Atlanta, GA, US

Rehovot, IL

Cancer and DNA genomic sequencing global company from Weizmann Institute of Science in Israel that provides market-fast, cost effective and flexible targeted panels for applications in oncology, carrier screening, COVID 19, and other diseases in 3 hours lab time. The company’s mission is to make targeted DNA sequencing as common, fast, and affordable as a.

Frankfort, IL, US

The Private Directors Association is the only national association dedicated exclusively to improving private companies' growth and sustainability through excellence in board formation and governance. Membership includes current and qualified future board members, private company owners, and C-level executives of family-owned businesses, ESOPs, venture.

Frankfort, IL, US

• Hired by two client companies as CCO/SVP of Commercial Operations and VP of Sales and Business Development after delivering successful outcomes through consulting (Cardinal Health, OpGen). Executed startups, M&A.
• Strategic Advisory Board member and consultant to VIC Technology Venture Development, Private Equity. License technologies/IP, fundraising, form startup companies, scale commercial growth, executive leadership
• Strategic Advisor, consultant to RCE Technologies (AI Medtech, medical devices), Proteas Bioanalytics. Commercial strategy, capital raise
• Advisor and consultant to COVID-19 diagnostic companies: Reliant Immune Diagnostics, MD Box, Anyplace-MD, BalinBac Therapeutics
• Strategic Advisory Board Member, EnSignis Digital Technology
• Advisor and Due Diligence Advisor (M & A) to venture capital and private equity companies including Commenda Capital, Asano Capital, Tings Capital. Seed-stage, early-stage life science/healthcare companies.

Execution of strategic partnerships, collaborations, and revenue streams. Board and executive roles ended due to dissolution of the board and restructuring of the company. Proteas Bioanalytics proteomic technology detects human diseases at their earliest stage, before the onset of symptoms, from a few drops of blood. Their advanced technologies provide.

Appointed Independent Board Director 2022, asked to join Executive Team by CEO in 2023; continued on Board of Directors. Board term ended due to dissolution of the board and restructuring of the company.

SF Bay Area, US

Cancer digital health company that partners with employee benefits programs, healthcare systems, and insurers to provide personalized cancer navigation services to anyone dealing with a cancer diagnosis-whether they are a patient, caregiver, or survivor-to help them better understand their diagnosis, evaluate treatment options, and plan the best path.

Atlanta, Georgia, US

Cybersecurity Leadership and Strategy Solutions, LLC (CLASS-LLC) is a cybersecurity and AI Artificial Intelligence strategy, risk management, and workforce development professional services firm. CLASS-LLC develops security programs that help organizations manage AI and cybersecurity risk while achieving their business goals. Professional certification.

Fayetteville, AR, US

VIC Technology Venture Development (VIC TVD) identifies and licenses promising healthcare innovation from top research institutions across the world and forms new companies to commercialize the technologies. VIC’s technology venture development business model has been optimized to overcome limitations of traditional technology transfer approaches and usurp.

Alpharetta, Georgia, US

Global IT company that delivers SaaS solutions for complex business problems with solutions-as-a-service model. The company focus is Digital Technologies, part of the EnSignis Company, and provides Advisory and Digital Transformation.

Carlsbad, California, US

• RCE Technologies is an AI med tech/medical device company that has developed an innovative ECG wearable and an optical based sensor device for non-invasive cardiac protein detection, which coupled with AI models can.
• Winner of the 2019 Southeast Medical Device Association (SEMDA) Pitch Rounds competition
• Selected as a Showcase Company for the Health Leaders Forum at the American Diabetes Association 11/1/19 in San Mateo, CA
• Selected as a Featured Company by the New England Venture Summit 12/4/19 in Boston, MA
• Selected as Featured Company in the Venture Atlanta Showcase 10/20 in Atlanta, GA

Rockville, Maryland, US

• Leadership of the global commercial operations of OpGen, a genomic / molecular diagnostics and bioinformatics early commercial stage company and AdvanDx, (acquired by OpGen), both leaders in genomic diagnostics.
• Increased revenue 32% in first two quarters; halted 5 year revenue decline in acquired product
• Drove 23% growth increase in target enterprise accounts: Cancer Centers of Excellence, hospitals/academic institutions, surgery centers, health systems/GPOs/IDNs, long-term care
• Spearheaded culture integration and commercial operations of two companies with acquisition of AdvanDx Diagnostics
• Reduced cost 19% by execution of restructuring and organic training: sales, marketing, advisory boards, KOLs
• Drove sales of new HIMMS analytic solutions and management platform/system (SaaS/IT) and subscriptions to enterprise customers, large high-tech hospitals, health systems/IDNs, clinical trials.

National foundation dedicated to serving bereaved children who have lost a parent by fulfilling traditions important to emotional and mental health and preserving memories of their lost parent, including the accompanying financial responsibility.

Dublin, OH, US

• Built and led U.S. commercial strategy, business development, supply chain, distribution, sales and marketing teams of start-up oncology, immunology, SaaS, health IT, specialty therapeutics division for Fortune 17.
• Hired and led cross-functional teams for Sales, Operations, Market Access, Managed Care / MCO, Strategic Business Development, Medical Affairs, HR, Sourcing, Specialty Pharmacy and Training for major oncology and.
• Built and led global start-up with $1.4B Profit & Loss responsibility.
• Directed 3 sales teams: outside, inside and telesales (call center)-oncology, neurology, surgery, infectious disease, rheumatology.
• $24M increase first year by development and execution of new contracts: GPOs, ACOs, IDNs, health systems, payers, providers, cancer centers, DoD, VA, managed care/MCOs.
• Increased revenue 23% YOY second full year of operation.

Lawrence Township, NJ, US

• Recruited to build a startup Biosurgery company from the ground floor up, 17 direct reports (surgical sales managers), grew to $27M in revenue. Executed operations of startup Surgery / OR division in new commercial.
• Exceeded 100% sales and management objectives while executing pre-launch hiring and product launch of start-up biotech surgical / OR national sales force in first commercial venture of medical devices and recombinant.
• Direct leadership of 17 Surgical Sales Managers (half of U.S. team)
• Exceeded annual sales objectives 2007-2009 by 128%, 134%, and 138%; highest achievement in company
• Sustained YOY revenue increases by developing and negotiating national account contracts to enterprise accounts: GPOs, IDNs, MCOs, DOD, surgery centers/OR/hospitals, health systems, cancer centers, payers, providers
• Reduced external training costs by 48% by developing and executing training programs for surgeons, OR sales force, KOL development, Market Access, MCO /GPO reimbursement.

Malvern, PA, US

• Recruited to turn around underperforming division. National leader of 180 member hospital surgical sales force, marketing, and home office personnel, 3.7B revenue, 6,400 employees. Directed U.S. operations of critical.
• Achieved 45% increase in sales within one year; turned around an underperforming division into a profitable unit.
• Catapulted 193% revenue increase in lead product by resolution of high impact shipping and storage issues
• Doubled previous year revenue to $248M: Sales, Marketing, Managed Care, Contracts, PBMs, GPO, IDNs
• Directed two new product launches and a major personnel expansion, enhancing product responsibility and credibility of the division.
• 13 Direct Reports: Marketing Director, 10 Regional Sales Directors, 2 National Account Directors

Paris, France, FR

• Recruited to build startup biotechnology company from ground floor, 27 direct reports-Clinical Science Managers, grew to $8.1B revenue, 10,100 employees. Recruited, hired, and promoted 27 diverse individuals in.
• Achieved 171% forecast/goal achievement in 1999, 168% forecast achievement in 2000-highest performing region in U.S.
• Exceeded forecast all seven years; region achieved highest US market share and YOY growth increase all years of tenure
• U.S. Circle of Excellence Winner 1999, 2000, and 2001 - #1 ranked region in forecast achievement in U.S.
• Achieved highest market share in U.S. 1999-2003, RBD Market Share Award Winner 1999–2003
• Appointed by President as Chairperson of Career Development, Succession Planning and Mentorship Program, 2000 - 2003

Cambridge, Cambridgeshire, GB

• Recruited to turn around underperforming division of Fortune 25 global company, $22B revenue, 61,600 employees worldwide. Leadership of 150 reports, managers, trainers, sales representatives, market access managers in.
• Transformed lowest performing region to second highest region in first year (from 87% to goal, #15/15 to 145% forecast achievement, #2/15), to highest performing region in U.S. in second year (158%, #1/15)
• Awarded President’s Circle Director Winner, 1997 (#1 ranked forecast achievement in U.S. of 950 Sales Personnel)
• P & L responsibility of $448M revenue, launched multiple oncology, hospital, surgery, urology, cardiology products
• Leadership of 150 FTEs, 15 Direct Reports: 13 Senior District Managers, National Accounts and Managed Care Managers, and Training Managers
• 158% Forecast Achievement 1998), highest region in U.S.

New Brunswick, NJ, US

• Recruited to build startup hospital division (medical device and therapeutics) for Fortune 15 multinational company, $76.5B revenue, 134,000 employees worldwide. 26 Direct reports: Surgical Managers, Hospital Sales.
• Developed contract responsible for $280 Million in U.S. quinolone sales in 2 years, and $1B brand within 4 years globally. Developed national hospital GPO/IDN contract. Resulted in 2,800 hospitals converting to product.
• Awarded J & J Executive of the Year - overall corporate contribution
• Exceeded corporate forecast YOY: 187%, 181%, 174% Forecast Achievement three consecutive years (1993 – 1995)
• Won President’s Cup Award three consecutive years: 1993, 1994, and 1995 (#1 ranked region in U.S.)
• Awarded Top Leader role by President: developed and led Management Training programs

Lawrence Township, NJ, US

• Promoted three times and to District Manager role. Led two sales teams (oncology and hospital/specialty sales) for Fortune 15 multinational company, $21B revenue, 24,000 employees worldwide. 22 direct reports
• Doubled revenue in two years; achieved $148M in revenue
• Achieved 157% forecast achievement in all products in 1987, 153% in 1988, 148% in 1989
• Awarded Manager of the Year 1988 (#1 ranked forecast achievement in U.S./153%)
• Winner of Great Performer Award 1988 (#1 ranked district in U.S.)
• Awarded District Manager of the Region Award (#1 ranked district in Southeast Region)

Lawrence Township, NJ, US

Promoted to Corporate Sales Trainer.Developed and implemented corporate training for all Eastern, Southwest, and Midwest U.S. sales representatives. Ran HQ corporate Sales Training programs and field-based training. 95% travel.

Lawrence Township, NJ, US

• Hospital, Oncology and Specialty Sales representative for multiple product line, Hispanic Territory (Little Havana) - All business conducted in Spanish.
• Achieved 186% Forecast Achievement 1985, 168% Forecast Achievement 1986
• Awarded Great Performers Award, Hospital/Specialty Sales Representative of the Year 1985, 1986 (#1 ranked in U.S.)
• Region Representative of the Year Award Winner, 1985 (highest forecast achievement in SE Region)
• Promoted to District Trainer 1985, 1986
• 154%, 148% Forecast Achievement 1984, 1985 for total prime products

Silicon Valley Executive Center, Women’S Corporate Board Readiness Program

Bachelor'S Degree (Through Suny), Business Administration And Management, Spanish

Bachelors Degree, Business Administration And Management, Spanish